Voximetry Launches Clinical Operations Support to accelerate adoption of Torch® Dose Assessment and Dosimetry Services
MADISON, Wis.– Voximetry Inc., a Healthtech company with software designed to change the Standard of Care for late-stage prostate cancer patients by creating personalized treatment plans tailored for the individual, has announced the appointment of Patrick Morse, MBA, as Vice President of Global Clinical Operations. Patrick has over 12 years of leadership experience in industry […]
Voximetry Announces Experienced Commercial Leadership Hired for Launch of Torch® Dose Assessment in the U.S.
MADISON, Wis.– Voximetry Inc., a Healthtech company with software designed to change the Standard of Care for late-stage prostate cancer patients by creating personalized treatment plans tailored for the individual, has announced the appointment of Michael Lafont, M.MSc., DABR as Vice President of Sales. Mr. Lafont has over 25 years of clinical and commercial leadership […]
Voximetry positions for growth with hiring of Chief Operating Officer Dr. Abhi Chakrabarti
MADISON, Wis.– Voximetry Inc., a Healthtech company with software designed to change the Standard of Care for late-stage prostate cancer patients by creating personalized treatment plans tailored for the individual, has announced the appointment of Dr. Abhimanyu Chakrabarti as Chief Operating Officer. Dr. Chakrabarti has over 25 years of global development and commercial leadership experience […]
Pluvicto Demonstrates Clinical Benefit in Prostate Cancer Before Chemo
Pluvicto becomes the first PSMA-targeted radioligand therapy to demonstrate clinical benefit in mCRPC patients BEFORE receiving taxane-based chemotherapy, addressing a significant unmet need Today, Novartis announced the pivotal Phase III PSMAfore study with PluvictoTM , a prostate-specific membrane antigen (PSMA)-targeted radioligand therapy, met its primary endpoint. This study is the first PSMA-targeted radioligand therapy to demonstrate […]
Voximetry Exhibits at SNMICON 2022 New Delhi, India
Voximetry is very pleased to participate in the 54th Annual Conference of the Society of Nuclear Medicine (India), SNMICON 2022, from December 8th -12th. We invite you to visit us during the exhibition at the booth of BJ. Madan & Co. and learn how Torch®, the accuracy leader and only full Monte Carlo GPU-accelerated voxel-based […]
Voximetry Receives FDA Clearance For Torch
MADISION, WI – Voximetry is very pleased to announce FDA 510(k) market clearance for Torch® Dose Assessment for Radiopharmaceutical Therapy (RPT), the first commercial full Monte Carlo GPU-accelerated voxel-based dosimetry solution. Torch can provide estimates of absorbed radiation dose following internal administration of approved radiopharmaceuticals, Torch can provide estimates of absorbed radiation dose in seconds. […]
Voximetry welcomes Dr. Richard Wahl as Chair of Scientific and Clinical Advisory Board
Voximetry is pleased to welcome Dr. Richard Wahl as Chair of the Scientific & Clinical Advisory Board for the company. Dr. Wahl was among the first to precisely target internal radiation therapy to cancers and has a successful track record of innovation from pre-clinical research to the clinic. His significant translational success includes 20 patents, […]
Voximetry signs new collaboration with Gemelli University Hospital IRCCS
Voximetry is proud to announce a product evaluation and research collaboration agreement for Torch® voxel-based Dose Assessment with Fondazione Policlinico Universitario A. Gemelli IRCCS. The collaboration intends to utilize Voximetry’s Torch® software* to research how a radiotherapeutic agent distributes in a specific patient and then report or predict the biologic effect on each tumor or […]
Voximetry Wins
“2022 Pressure Chamber”
Investor Pitch Competition
The Madison Wisconsin Chamber of Commerce “Pressure Chamber” event returned for its ninth year as emerging companies again competed for the coveted “golden suitcase,” as well as a reserved spot in the Chamber’s exclusive Greater Madison startup meetings with top Silicon Valley investment firms this fall. Over 300 companies competed to pitch in front of […]
Voximetry selected as finalist for the 2022 Wisconsin Innovation Awards
Voximetry is proud to announce we have been selected as a finalist from more than 300 businesses, products and services for the 2022 Wisconsin Innovation Awards. We are extremely grateful for the opportunity to share our exciting work on personalized RPT treatment planning making a difference for cancer patients everywhere. For more information, click here. […]